- Home
- SYNX vs RLYB Comparison
SYNX vs RLYB Comparison
Compare SYNX & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNX
- RLYB
- Stock Information
- Founded
- SYNX 2005
- RLYB 2018
- Country
- SYNX Israel
- RLYB United States
- Employees
- SYNX N/A
- RLYB N/A
- Industry
- SYNX
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- SYNX
- RLYB Health Care
- Exchange
- SYNX Nasdaq
- RLYB Nasdaq
- Market Cap
- SYNX 11.9M
- RLYB 13.3M
- IPO Year
- SYNX 2024
- RLYB 2021
- Fundamental
- Price
- SYNX $1.85
- RLYB $0.32
- Analyst Decision
- SYNX
- RLYB Hold
- Analyst Count
- SYNX 0
- RLYB 4
- Target Price
- SYNX N/A
- RLYB $15.00
- AVG Volume (30 Days)
- SYNX 30.5K
- RLYB 70.4K
- Earning Date
- SYNX 05-14-2025
- RLYB 05-08-2025
- Dividend Yield
- SYNX N/A
- RLYB N/A
- EPS Growth
- SYNX N/A
- RLYB N/A
- EPS
- SYNX N/A
- RLYB N/A
- Revenue
- SYNX $9,094,000.00
- RLYB $848,000.00
- Revenue This Year
- SYNX N/A
- RLYB N/A
- Revenue Next Year
- SYNX N/A
- RLYB N/A
- P/E Ratio
- SYNX N/A
- RLYB N/A
- Revenue Growth
- SYNX 19.14
- RLYB N/A
- 52 Week Low
- SYNX $1.70
- RLYB $0.22
- 52 Week High
- SYNX $6.49
- RLYB $2.00
- Technical
- Relative Strength Index (RSI)
- SYNX 39.25
- RLYB 43.98
- Support Level
- SYNX $1.82
- RLYB $0.29
- Resistance Level
- SYNX $2.06
- RLYB $0.32
- Average True Range (ATR)
- SYNX 0.13
- RLYB 0.02
- MACD
- SYNX 0.07
- RLYB 0.01
- Stochastic Oscillator
- SYNX 41.67
- RLYB 75.25
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.